Literature DB >> 25708337

Dihydroquercetin effects on the morphology and antioxidant/prooxidant balance of the prostate in rats with sulpiride-induced benign hyperplasia.

T G Borovskaya1, N A Krivova, O B Zaeva, T I Fomina, S I Kamalova, M E Poluektova, A V Vychuzhanina, Yu A Shchemerova, V A Grigor'eva, V E Goldberg, M B Plotnikov.   

Abstract

A course of dihydroquercetin (antioxidant) injections to 5-month-old Wistar rats with sulpiride-induced benign prostatic hyperplasia led to reduction of proliferative activity in the glandular structures and to attenuation of the inflammatory reaction in the tissue. Prostatic antioxidant/prooxidant balance returned to normal after the treatment.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25708337     DOI： 10.1007/s10517-015-2797-9

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN： 0007-4888            Impact factor:   0.804


  3 in total

Review 1.  Management of Benign Prostatic Hyperplasia: Could Dietary Polyphenols Be an Alternative to Existing Therapies?

Authors:  Chinedum Eleazu; Kate Eleazu; Winner Kalu
Journal:  Front Pharmacol       Date:  2017-04-28       Impact factor: 5.810

2.  Chemical profiles of the active fraction from Prinsepia utilis Royle leaves and its anti-benign prostatic hyperplasia evaluation in animal models.

Authors:  Ying Peng; Chongsheng Peng; Yang Wu; Chongzhi Sun; Xiaobo Li
Journal:  BMC Complement Med Ther       Date:  2021-10-29

3.  Simulation studies, 3D QSAR and molecular docking on a point mutation of protein kinase B with flavonoids targeting ovarian Cancer.

Authors:  Suchitra Maheswari Ajjarapu; Apoorv Tiwari; Gohar Taj; Dev Bukhsh Singh; Sakshi Singh; Sundip Kumar
Journal:  BMC Pharmacol Toxicol       Date:  2021-11-02       Impact factor: 2.483
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.